Covered recipient · General Payments record
ROBERT EZEWUIRO
Podiatric Medicine & Surgery Service Providers Podiatrist Primary Podiatric Medicine
General Payments · PY2018–2024
$21,113.33
- Reported across 222 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $994.67 | 32 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ConvaTec Inc. | $490.26 | 18 |
| Stryker Corporation | $213.00 | 4 |
| Amgen Inc. | $121.89 | 1 |
| Smith & Nephew, Inc. | $37.34 | 2 |
| Paratek Pharmaceuticals, Inc. | $32.75 | 2 |
| Peerless Surgical Inc. | $30.89 | 1 |
| Kerecis Limited | $21.53 | 1 |
| Advanced Oxygen Therapy Inc. | $18.87 | 1 |
| DePuy Synthes Sales Inc. | $14.33 | 1 |
| Bioventus LLC | $13.81 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (32)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Advanced Oxygen Therapy Inc. | $18.87 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117466771 | CMS |
| Amgen Inc. | $121.89 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115610366 | CMS |
| Bioventus LLC | $13.81 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137439942 | CMS |
| ConvaTec Inc. | $16.40 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373606 | CMS |
| ConvaTec Inc. | $25.20 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373608 | CMS |
| ConvaTec Inc. | $16.77 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373610 | CMS |
| ConvaTec Inc. | $17.81 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373612 | CMS |
| ConvaTec Inc. | $14.01 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373614 | CMS |
| ConvaTec Inc. | $28.66 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373616 | CMS |
| ConvaTec Inc. | $27.09 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373618 | CMS |
| ConvaTec Inc. | $16.29 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373620 | CMS |
| ConvaTec Inc. | $18.98 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373622 | CMS |
| ConvaTec Inc. | $19.29 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373624 | CMS |
| ConvaTec Inc. | $6.62 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373626 | CMS |
| ConvaTec Inc. | $8.45 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373628 | CMS |
| ConvaTec Inc. | $80.35 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373630 | CMS |
| ConvaTec Inc. | $18.81 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373632 | CMS |
| ConvaTec Inc. | $133.39 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373634 | CMS |
| ConvaTec Inc. | $13.42 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373636 | CMS |
| ConvaTec Inc. | $18.95 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373638 | CMS |
| ConvaTec Inc. | $9.77 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151373640 | CMS |
| DePuy Synthes Sales Inc. | $14.33 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1077888142 | CMS |
| Kerecis Limited | $21.53 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120101965 | CMS |
| Paratek Pharmaceuticals, Inc. | $18.32 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113899387 | CMS |
| Paratek Pharmaceuticals, Inc. | $14.43 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113899389 | CMS |
| Peerless Surgical Inc. | $30.89 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125525383 | CMS |
| Smith+Nephew, Inc. | $13.25 | 04/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149534953 | CMS |
| Smith+Nephew, Inc. | $24.09 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149534955 | CMS |
| Stryker Corporation | $65.29 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824837 | CMS |
| Stryker Corporation | $52.59 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824839 | CMS |
| Stryker Corporation | $38.08 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824841 | CMS |
| Stryker Corporation | $57.04 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119824843 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.